Public Health Approach to Birth Defects, Developmental Disabilities, and Genetic Conditions

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 125 C, Issue 1, 2004, Pages 1-3

  Rasmussen, Sonja A ^a,b   Moore, Cynthia A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Div Birth Defects/Devmtl Disabil   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIRTH DEFECT; DEVELOPMENTAL DISORDER; EDITORIAL; ENVIRONMENTAL FACTOR; HEALTH PRACTITIONER; MEDICAL INFORMATION SYSTEM; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0942265685     PISSN: 15524868     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.c.30003     Document Type: Editorial

References (27)

1. Beaty TH, Wang H, Hetmanski JB, Fan YT, Zeiger JS, Liang KY, Chiu YF, Vanderkolk CA, Seifert KC, Wulfsberg EA, Raymond G, Panny SR, McIntosh I. 2001. A case-control study of nonsyndromic oral clefts in Maryland. Ann Epidemiol 11:434-442.
2. Centers for Disease Control and Prevention. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 41:1-7.
3. Centers for Disease Control and Prevention. 2003. HIPAA privacy rule and public health. Guidance from CDC and the U.S. Department of Health and Human Services. MMWR Morb Mortal Wkly Rep 52 (Suppl):1-17, 19-20.
4. Clayton EW. 2003. Ethical, legal, and social implications of genomic medicine. N Engl J Med 349:562-569.
5. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832-1835.
6. Edmonds LD, Layde PM, James LM, Flynt JW, Erickson JD, Oakley GP Jr. 1981. Congenital malformations surveillance: two American systems. Int J Epidemiol 10:247-252.
7. Friedman JM. 1992. The use of dysmorphology in birth defects epidemiology. Teratology 45:187-193.
8. Gilani SH. 1975. Congenital abnormalities in methylmercury poisoning. Environ Res 9:128-134.
9. Guthrie R, Susi A. 1963. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32:338-343.
10. Guttmacher AE, Collins FS. 2002. Genomic medicine-a primer. N Engl J Med 347:1512-1520.
11. Holtzman NA, Khoury MJ. 1986. Monitoring for congenital malformations. Annu Rev Public Health 7:237-266.
12. Joint Committee on Infant Hearing. 2000. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, American Speech-Language-Hearing Association, and Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Pediatrics 106:798-817.
13. Khoury MJ. 2003. Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med 5:261-268.
14. Lenz W. 1988. A short history of thalidomide embryopathy. Teratology 38:203-215.
15. Lowry RB, Thunem NY, Anderson-Redick S. 1989. Alberta congenital anomalies surveillance system. Canadian Medical Association Journal 141:1155-1159.
16. Oakley GP Jr. 1985. Birth defects epidemiology and surveillance. Prog Clin Biol Res 163A:71-90.
17. Rasmussen SA, Lammer EJ, Shaw GM, Finnell RH, McGehee RE Jr, Gallagher M, Romitti PA, Murray JC. 2002. Integration of DNA sample collection into a multi-site birth defects case-control study. Teratology 66:177-184.
18. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA. 2003. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res Part A Clin Mol Teratol 67:193-201.
19. Rhoads GG, Mills JL. 1984. The role of the case-control study in evaluating health interventions. Vitamin supplementation and neural tube defects. Am J Epidemiol 120:803-808.
20. Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH. 2002. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 108:1-6.
21. Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, Majnemer A, Noetzel M, Sheth RD. 2003. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 60:367-380.
22. Veenstra-Vanderweele J, Cook E Jr, Lombroso PJ. 2003. Genetics of childhood disorders: XLVI. Autism, part 5: genetics of autism. J Am Acad Child Adolesc Psychiatry 42:116-118.
23. Yeargin-Allsopp M, Murphy CC, Oakley GP, Sikes RK. 1992. A multiple-source method for studying the prevalence of developmental disabilities in children: the Metropolitan Atlanta Developmental Disabilities Study. Pediatrics 89:624-630.
24. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. 2003. Prevalence of autism in a U.S. metropolitan area. JAMA 289:49-55.
25. Yoon PW, Rasmussen SA, Lynberg MC, Moore CA, Anderka M, Carmichael SL, Costa P, Druschel C, Hobbs CA, Romitti PA, Langlois PH, Edmonds LD. 2001. The National Birth Defects Prevention Study. Public Health Rep 116:32-40.
26. Yoon PW, Scheuner MT, Peterson-Oehlke KL, Gwinn M, Faucett A, Khoury MJ. 2002. Can family history be used as a tool for public health and preventive medicine? Genet Med 4:304-310.
27. Yoon PW, Scheuner MT, Khoury MJ. 2003. Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 24:128-135.